BLTE

Belite Bio Inc ADR

NASDAQ: BLTE · HEALTHCARE · BIOTECHNOLOGY

$151.97

-0.77% today

Updated 2026-06-05

Market cap

$5.54B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.54

Dividend yield

—

52W range

$56 – $200

Volume

0.2M

Market cap

$5.54B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-2.54

Dividend yield

—

52W range

$56 – $200

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.8

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$210.50

+38.51%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-12.65M	$-31.63M	$-36.14M	$-77.61M	$-26.94M
EPS	—	—	—	—	$-2.54
Free cash flow	$-11.85M	$-29.90M	$-29.39M	$-37.17M	—
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BLTE	$5.54B	20	4.3	3.0	5.0	4.8	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Belite Bio Inc ADR trades at $151.97. Our Smart Value Score of 20/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score.

Frequently asked questions

What is Belite Bio Inc ADR's stock price?

Belite Bio Inc ADR (BLTE) trades at $151.97.

Is Belite Bio Inc ADR overvalued?

Belite Bio Inc ADR carries a Smart Value Score of 20/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Belite Bio Inc ADR (BLTE)?

The 12-month analyst consensus target is $210.50, about 38.5% above the current $151.97. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-11.34%

Beta-1.24

50D MA$154.17

200D MA$136.76

Shares out0.04B

Float0.02B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

BLTE vs LLY →BLTE vs JNJ →BLTE vs ABBV →Stock screener →